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Leptin at 3 months correlated with subcutaneous fat at 
3 months (r = 0.23, p < 0.001), but not with visceral fat. 
Other ARH did not correlate with body composition.
Conclusion Formula-fed infants had a different profile of 
ARH than breastfed infants, suggesting that lower levels of 
ghrelin, leptin and insulin in breastfed infants contribute to 
the protective role of breastfeeding against obesity develop-
ment. Leptin, ghrelin and insulin were associated with fat 
mass percentage or its changes.
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Introduction
Childhood obesity is a worldwide problem with an 
increasing prevalence of 7–11 % in Dutch children aged 
4–12 years [1]. It is not only associated with short-term 
morbidity, but also associated with long-term morbidity, 
such as adult obesity, type 2 diabetes and cardiovascular 
diseases [2–4]. Accelerated weight gain during the first 
3 months of life is associated with accumulation of fat mass 
during childhood and a worse cardiovascular and meta-
bolic profile in young adulthood [5–7]. Appetite-regulating 
hormones play a role in the regulation of food intake and 
body composition by signaling satiety and energy reserves 
through hypothalamic receptors [8]. However, little is 
known about the relation between body composition and 
appetite-regulating hormones in early life [9].
Changes in body composition might be influenced by 
programming of the orexigenic and anorectic appetite-
regulating hormones [10]. Orexigenic appetite stimu-
lating hormones, such as ghrelin, are important in the 
initiation, cessation and frequency of eating. Anorectic 
Abstract 
Introduction Body composition in early life influences 
development of obesity during childhood and beyond. 
Appetite-regulating hormones (ARH) play a role in regula-
tion of food intake and might thus influence body composi-
tion in later life. Studies on associations between ARH and 
body composition in early life are limited.
Methods In 197 healthy term infants, we measured serum 
fasting levels of ghrelin, leptin, insulin, glucose-dependent 
insulinotropic peptide (GIP), pancreatic polypeptide (PP) 
and peptide YY (PYY) at 3 months and in 41 infants also 
at 6 months and their associations with type of feeding and 
longitudinal fat mass percentage (FM%) measured by air 
displacement plethysmography at 1, 3 and 6 months and 
abdominal visceral and subcutaneous fat, measured by 
ultrasound, at 3 and 6 months.
Results Infants with formula feeding for 3 months had sig-
nificantly higher serum levels of ghrelin, leptin, insulin, 
GIP and PP (p = 0.026, p = 0.018, p = 0.002, p < 0.001, 
resp.) and lower serum levels of PYY (p = 0.002) at 
3 months than breastfed infants. Leptin and ghrelin cor-
related positively with FM% at 3 months and insulin 
with change in FM% between 1 and 3 months (r = 0.40, 
p < 0.001, r = 0.23, p < 0.05, r = 0.22, p < 0.01, resp.). 
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appetite-regulating hormones, such as leptin and peptide 
YY (PYY), decrease food intake and increase metabolic 
rate. The glucose-dependent insulinotropic peptide (GIP) 
stimulates pancreatic beta cells in response to the ingestion 
of meals or glucose [11, 12]. All these signals act at several 
sites in the central nervous system (CNS), but the pathways 
converge to the hypothalamus, which contains a large num-
ber of peptides and other neurotransmitters that influence 
food intake.
The protective role of breastfeeding for obesity could be 
partly explained by the composition of the human milk, but 
probably also by different appetite-regulating hormones in 
infants due to breastfeeding. Knowledge about the changes 
in appetite-regulating hormones during infancy is very lim-
ited [13].
We hypothesized that formula-fed infants would have 
a different profile of serum appetite-regulating hormones 
than breastfed infants and that fasting serum ghrelin, leptin 
and insulin levels would be positively associated with gain 
in weight and in fat mass during the first 3 months after 
birth, while GIP, PP and PYY levels would be negatively 
associated. We, therefore, investigated fasting serum levels 
of ghrelin, leptin and insulin, GIP, PP and PYY at 3 months 
and associated these with type of feeding and body compo-
sition, including FM% and visceral and subcutaneous fat at 
3 and 6 months.
Materials and methods
Subjects
The current study is part of a birth cohort study (Sophia 
Pluto Study) which started in January 2013, aiming to pro-
vide detailed data on body composition and growth in early 
life.
Serum levels of appetite-regulating hormones (ghrelin, 
leptin, insulin, GIP, PYY and PP) were determined in a ran-
dom subgroup of 197 infants at 3 months of age and in 41 
of them also at 6 months of age.
Infants were recruited from several hospitals in and 
near Rotterdam, a large city in The Netherlands. All par-
ticipants fulfilled the same inclusion criteria: (1) born term 
(≥37 weeks of gestation), (2) age <28 days and (3) uncom-
plicated neonatal period without signs of severe asphyxia 
(defined as an Apgar score below three after 5 min), sepsis 
or long-term complication of respiratory ventilation. Exclu-
sion criteria were known congenital or postnatal diseases 
that could interfere with body composition development, 
confirmed intrauterine infection, maternal use of corticos-
teroids or significant maternal medical condition that could 
interfere with infant’s body composition development (e.g., 
diabetes).
The Medical Ethics Committee of Erasmus Medi-
cal Center approved the study. Written informed con-
sent was obtained from both parents unless mother was 
single.
Data collection and measurements
Information about the type of feeding was recorded during 
outpatient clinic visits.
Infant characteristics
Research clinic visits were scheduled at 1, 3 and 6 months. 
Birth data were taken from midwife and hospital records. 
Trained pediatric nurses took the measurements according 
to standard procedures.
Anthropometrics Weight was measured to the nearest 
gram by an electronic infant scale (Seca, Hanover, MD). 
Length was measured to the nearest 0.1 cm by a length 
meter (Seca). Head circumference was measured to the 
nearest 0.1 cm using measuring tape (Seca, circumeter). 
Weight SDS, height SDS and weight for length SDS were 
calculated with Growth Analyser Research Calculation 
Tools 4.0 (available at www.growthanalyser.org), accord-
ing to Dutch age- and gender-matched reference values 
[14].
Body composition Whole-body composition was 
assessed using air displacement plethysmography (Peapod, 
Infant Body Composition System, COSMED). A detailed 
description of the air displacement plethysmography 
(ADP) system is provided elsewhere [15–18]. Briefly, this 
ADP system assesses fat mass (FM), fat mass percentage 
(FM%) and fat-free mass (FFM) and fat-free mass percent-
age (FFM%) by direct measurements of body volume and 
body mass, based on the whole-body densitometric princi-
ple. All measurements were obtained by experienced per-
sonnel, according to standardized protocol. The Peapod 
was calibrated every day, according to the protocol recom-
mended by the supplier.
Abdominal fat Visceral and abdominal subcutaneous 
fat was measured at 3 and 6 months using a Prosound 2 
ultrasound, with a UST-9137 convex ultrasound transducer 
(both from Hitachi Aloka Medical, Switzerland). For both 
measures, the transducer was positioned where the xiphoid 
line intercepted the waist circumference measurement 
plane. Visceral fat was estimated by measuring visceral 
depth, which is the distance between the peritoneal bound-
ary and the corpus of the lumbar vertebra, assessed in the 
longitudinal plane with the ultrasound probe depth set at 
9 cm. Subcutaneous abdominal fat was estimated by the 
distance between the cutaneous boundary and the linea alba 
at the same location, but on a transverse plane with a probe 
depth of 4 cm [19].
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Collection of blood and assays
At 3 months, blood samples were collected from a heel 
prick after the infants had fasted for at least 3 h. To stabi-
lize the appetite-regulating hormones, blood samples were 
collected in EDTA tubes and dipeptidyl peptidase-4 inhibi-
tor (DPP4-inhibitor, Merck Chemicals) and 4-(2-ami-
noethyl)benzenesulfonyl fluoride hydrochloride (serine 
protease inhibitor, Calbiochem) were added at the time 
of collection. Blood was centrifuged at 4 °C to prepare 
plasma, which was quickly frozen. Samples were stored at 
−80 °C.
Ghrelin (active), leptin, insulin, GIP, PP and PYY 
concentrations in serum were determined by the MILLI-
PLEX MAP Human Metabolic Hormone Magnetic Bead 
Panel, catalog number HMHMAG-34K (Millipore Cor-
poration, Billerica, MA) using the commercial protocol. 
The intra-assay CV was <10 %, and the inter-assay CV 
was <15 %.
Statistical analysis
Descriptive results are expressed as median (interquar-
tile range). Differences between groups were examined 
using Mann–Whitney U tests. We assessed linear corre-
lations between levels of ghrelin, leptin, insulin, GIP, PP 
and PYY and other parameters using Pearson’s correla-
tion coefficient. Correlation coefficient below 0.20 was 
considered to be a negligible correlation. SPSS statisti-
cal package version 20.0 (SPSS Inc. Chicago, Illinois) 
was used. All statistical tests were performed two-sided, 
and results were regarded statistically significant if the P 
value was <0.05.
Results
Clinical characteristics of the infants are presented in 
Table 1. The median (IQR) gestational age was 39.9 (38.9–
40.6) weeks, and 53 % of the infants were boys. Forty-one 
boys had their appetite-regulating hormones longitudinally 
determined at 3 and 6 months. Fifty-six percentage of the 
infants received exclusive breastfeeding at 1 month, 32 % 
at 3 months, and 16 % at 6 months.
Table 2 shows serum levels of ghrelin, leptin, insulin, 
GIP, PP and PYY at 3 and 6 months. Median fasting time 
had been 3.00 (2:30–3:40) hours at 3 months and 2.52 
(2:13–4:15) hours at 6 months. Ghrelin, GIP and PP lev-
els increased significantly from 3 to 6 months (p < 0.001, 
p = 0.016, p < 0.001, resp.), while the leptin levels 
decreased between 3 and 6 months (p = 0.009).
There were no differences in appetite-regulating hor-
mone levels between boys and girls (Table 2).
Associations between appetite‑regulating hormones 
and type of feeding
Table 3 shows the serum levels of appetite-regulating hor-
mones during exclusively formula feeding versus exclusively 
breastfeeding for 3 months. There were no significant differ-
ences in weight SDS, FM%, visceral and subcutaneous fat 
at 1, 3 and 6 months between the formula-fed and breastfed 
infants, but all appetite-regulating hormones were different 
between the formula-fed and breastfed groups. Serum lev-
els of ghrelin, leptin, insulin, GIP and PP were significantly 
higher in the formula-fed group compared to the breastfed 
group (p = 0.026, p = 0.018, p = 0.002, p < 0.001, resp.), 
whereas PYY was significantly lower (p = 0.002).
At 3 months, a shorter duration of exclusive breastfeed-
ing correlated only with a higher PP level (r = −0.24, 
p = 0.005). At 6 months, we found no significant correla-
tions of duration of breastfeeding with appetite-regulating 
hormones.
Associations between appetite‑regulating hormones 
and fat mass percentage
Serum leptin at 3 months correlated with fat mass percent-
age (FM%) at that age (r = 0.37, p < 0.001) (Table 4). 
Similar associations were found between serum leptin 
at 3 months and FM% at 6 months (r = 0.41, p < 0.001). 
Serum insulin at 3 months correlated with the increase in 
FM% between 1 and 3 months (r = 0.22, p < 0.01). The 
other appetite-regulating hormones did neither correlate 
with FM% nor correlate with changes in FM%. We found 
in the formula-fed infants a positive correlation between 
ghrelin at 3 months and FM% (r = 0.23, p < 0.05) at that 
age. In the breastfed infants, we did not find this correla-
tion, but a stronger correlation between leptin and FM% 
(r = 0.61, p < 0.001) (data not shown).
Associations between appetite‑regulating hormones 
and visceral and subcutaneous fat
Serum leptin, ghrelin and insulin at 3 months did not correlate 
with visceral and subcutaneous fat at 3 and 6 months. Breast-
fed infants showed a correlation between leptin and subcuta-
neous fat at 3 months (r = 0.38, p < 0.01) (data not shown).
Associations between appetite‑regulating hormones 
and anthropometrics
As a proxy for body composition, anthropometrics are 
often used. We, therefore, also analyzed correlations 
between appetite-regulating hormones and anthropomet-
rics. Serum leptin at 3 months correlated positively with 
weight for length SDS at 3 months (r = 0.48, p < 0.001) 
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and 6 months (data not shown) (Table 4). A higher PYY at 
3 months correlated with lower weight for length SDS at 
3 months (r = −0.23, p < 0.01). Serum leptin and insulin at 
3 months correlated with the increase in weight for length 
SDS between 1 and 3 months of life (r = 0.45, p < 0.001, 
r = 0.20, p < 0.01, resp.).
Discussion
In this study, we investigated the fasting serum levels of 
appetite-regulating hormones, such as ghrelin, leptin, 
insulin, GIP, PP and PYY in infants at 3 and 6 months and 
their associations with type of feeding, FM%, visceral fat 
and subcutaneous fat. Interestingly, all appetite-regulating 
hormones were different between infants with formula 
feeding compared to the breastfed infants. Serum levels 
of ghrelin, leptin, insulin, GIP and PP were significantly 
higher in the formula-fed group, whereas PYY was sig-
nificantly lower. Leptin at 3 months correlated positively 
with FM% at 3 and 6 months, but only with subcutane-
ous fat and not with visceral fat. Also ghrelin at 3 months 
correlated with FM% at 3 months, but only in formula-fed 
infants. Serum insulin correlated positively with gain in 
Table 1  Clinical characteristics
Data expressed as median (interquartile range)
Significant P values are indicated in boldface. # Differences between total group and subgroup
Total group Girls
(n = 93)
Boys
(n = 104)
p value ♀ versus ♂ Subgroup(n = 41) p value
#
(n = 197)
Birth
Gestational age (weeks) 39.9 38.9 to 40.6 39.9 39.7 0.58 39.4 0.03
Birth weight SDS −0.38 −1.12 to 0.33 −0.42 −0.35 0.60 −0.85 0.08
Birth length SDS 0.13 −1.05 to 0.80 0.13 −0.38 0.47 −0.97 0.10
Age 1 month
Age (months) 0.95 0.92 to 1.05 0.95 0.99 0.38 0.95 0.34
Weight SDS 0.33 −0.51 to 1.09 0.42 0.33 0.79 −0.04 0.09
Length SDS 0.04 −0.61 to 0.68 0.04 0.02 0.61 −0.11 0.03
Sum of peripheral skinfolds (mm) 11.0 10.0 to 13.0 11.0 11.0 0.73 11.0 0.33
Sum of central skinfolds (mm) 11.0 9.0 to 12.0 11.0 11.0 0.67 11.0 0.46
Fat mass (kg) 0.68 0.54 to 0.86 0.65 0.73 0.62 0.74 0.65
Fat mass percentage (%) 16.4 13.7 to 19.4 16.5 16.3 0.39 17.7 0.49
Age 3 months
Age (months) 2.99 2.92 to 3.06 2.99 2.99 0.90 2.99 0.40
Weight SDS 0.49 −0.24 to 1.22 0.36 0.57 0.05 0.27 0.58
Length SDS 0.43 −0.17 to 0.90 0.27 0.56 0.04 0.18 0.14
Sum of peripheral skinfolds (mm) 15.0 13.0 to 16.0 14.0 15.0 0.10 15.0 0.28
Sum of central skinfolds (mm) 13.0 11.0 to 15.0 12.0 13.0 0.53 13.0 0.05
Fat mass (kg) 1.33 1.12 to 1.59 1.29 1.37 0.23 1.32 0.79
Fat mass percentage (%) 22.6 19.7 to 25.8 23.1 22.4 0.34 23.2 0.92
Visceral fat (cm) 2.53 2.03 to 2.89 2.39 2.54 0.23 2.54 0.31
Abdominal subcutaneous fat (cm) 0.42 0.35 to 0.50 0.42 0.43 0.14 0.41 0.42
Age 6 months
Age (months) 6.01 5.95 to 6.11 6.01 6.01 0.57 5.98 0.57
Weight SDS 0.14 −0.31 to 0.71 0.06 0.18 0.33 0.09 0.37
Length SDS 0.29 −0.34 to 0.78 0.25 0.31 0.64 0.20 0.14
Sum of peripheral skinfolds (mm) 16.0 14.0 to 17.0 17.0 15.0 0.18 15.0 0.75
Sum of central skinfolds (mm) 12.0 11.0 to 15.0 13.0 12.0 0.36 13.0 0.85
Fat mass (kg) 1.76 1.44 to 2.09 1.79 1.75 0.42 1.70 0.31
Fat mass percentage (%) 23.5 20.2 to 27.3 24.8 22.8 <0.01 22.6 0.16
Visceral fat (cm) 2.34 2.00 to 2.84 2.34 2.45 0.80 2.19 0.91
Abdominal subcutaneous fat (cm) 0.41 0.35 to 0.51 0.45 0.41 0.63 0.40 0.39
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FM% between 1 and 3 months. Other appetite-regulating 
hormones were not associated with fat mass percentage and 
visceral fat in the first 3–6 months.
We show that formula-fed infants have different levels 
of appetite-regulating hormones than infants with exclusive 
breastfeeding. For healthy term infants, exclusive breast-
feeding is considered the reference to which formula feed-
ing must be compared. Serum levels of ghrelin were signifi-
cantly higher in formula fed than in breastfed infants. These 
data are in line with a cross-sectional study where the same 
results were found in the first year of life in a group of Ital-
ian infants [20]. It has been demonstrated in animal stud-
ies that neonatal ghrelin is important for normal maturation 
Table 2  Serum levels of appetite-regulating hormones in infants at 3 and 6 months of age
Data expressed as median (interquartile range)
Significant P values are indicated in boldface
3 months 6 months p value girls vs.  
boys at 3 months
Girls Boys Boys
Total group (n = 197)
Hours fasting (h) 2:50 2:22–3:30 3:12 2:30–3:55 0.11
Ghrelin (pg/ml) 44.0 23.4–82.1 48.9 23.4–68.3 0.57
Leptin (pg/ml) 1439.6 875.3–2364.7 1405.2 742.6–2001.4 0.24
Insulin (pg/ml) 369.0 232.3–619.5 430.5 265.7–738.1 0.30
GIP (pg/ml) 244.8 133.0–393.1 237.3 138.5–350.8 0.87
PP (pg/ml) 59.8 31.7–94.2 68.3 46.5–104.1 0.08
PYY (pg/ml) 210.6 159.4–293.8 196.9 156.3–250.8 0.24
p value 3 versus 
6 months
Subgroup (n = 41)
Hours fasting (h) 3:25 2:38–4:00 2.52 2.13–4.15 0.252
Ghrelin (pg/ml) 46.2 20.2–67.6 83.1 48.7–102.6 <0.001
Leptin (pg/ml) 1560.4 945.4–1991.4 827.2 424.6–1247.2 <0.001
Insulin (pg/ml) 464.9 291.6–718.5 483.8 324.4–635.6 0.821
GIP (pg/ml) 263.1 137.1–345.4 310.9 201.5–421.1 0.008
PP (pg/ml) 70.9 41.4–127.8 115.7 68.4–241.6 <0.001
PYY (pg/ml) 171.6 150.1–231.7 158.7 130.7–205.6 0.065
Table 3  Serum levels of appetite-regulating hormones in 197 infants 
at 3 months, divided by type of feeding
Data were expressed as medians. Significant P values are indicated in 
boldface
Exclusive FF at 
3 months
Exclusive BF at 
3 months
p value
Ghrelin (pg/ml) 49.1 33.2 0.026
Leptin (pg/ml) 1719.1 1190.1 0.018
Insulin (pg/ml) 560.9 287.8 <0.001
GIP (pg/ml) 304.1 198.5 0.002
PP (pg/ml) 87.7 46.3 <0.001
PYY (pg/ml) 180.2 231.0 0.002
Table 4  Correlations of appetite-regulating hormones with body composition and anthropometry at 3 months in 197 infants
Significant P values are indicated in boldface if r > 0.20 and p < 0.05; ^ p < 0.05; * p < 0.01; ** p <  0.001
FM% Delta FM% 1–3 
months
Visceral fat Subcutaneous fat Weight for length 
SDS
Delta weight for length 
SDS 1–3 months
Ghrelin (pg/ml) 0.11 0.01 <0.01 <0.01 0.06 0.04
Leptin (pg/ml) 0.37** 0.04 0.01 0.16^ 0.48** 0.45**
Insulin (pg/ml) <0.01 0.22* 0.19* −0.01 0.08 0.20*
GIP (pg/ml) 0.03 −0.16^ 0.11 −0.08 0.04 0.13
PP (pg/ml) 0.04 −0.02 0.04 −0.02 0.03 0.09
PYY (pg/ml) −0.08 0.03 0.03 −0.12 −0.23* −0.12
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of hypothalamic neural circuits. The neural developmental 
activity of ghrelin is essentially restricted to the neonatal 
period [21]. Proper expression of ghrelin during neona-
tal life is, therefore, crucial for lifelong metabolic regula-
tion, and too high ghrelin levels during the first months of 
life result in lifelong metabolic disturbances [22]. In the 
formula-fed infants, we did not find very high levels of 
ghrelin, but their levels were significantly higher than in 
the breastfed infants. In this critical period, this could have 
adverse effects on the maturation of the hypothalamic neu-
ral circuits, resulting in less favorable metabolic regula-
tion in later life [23]. We found also higher leptin levels in 
formula-fed infants. Like ghrelin, leptin is known to pro-
mote the development of the arcuate nucleus in the hypo-
thalamus, and its developmental action is also restricted to 
a critical window in the first months of life [24], but higher 
ghrelin levels could impair leptin signaling in the arcuate 
nucleus in early life [21]. Our data are in line with another 
study, reporting higher leptin levels in formula-fed infants 
compared to breastfed infants [25]. However, in a study in 
infants with a smaller group of subjects, breastfed infants 
had higher leptin levels than formula-fed infants [26].
Infants with formula feeding had lower levels of PYY. 
One of the actions of PYY is to reduce food intake by 
reducing the gastro-intestinal tract motility and the gastric 
emptying, via the vagal–brainstem–hypothalamic pathway 
[27]. As the breastfed infants had higher PYY levels, that 
could be a link in the protective role of breastfeeding for 
obesity. In addition, we found that higher levels of PYY 
were associated with a lower weight for length SDS at 
3 months. These results are in line with the data of Hel-
sinki Birth Cohort Study, where they found higher PYY 
levels in adulthood when the infants had a lower growth 
rate during infancy [28]. Our study shows that these dif-
ferences can already be found in early life. Infants with 
formula feeding had also higher levels of insulin, GIP and 
PP. A possible explanation of the higher insulin levels in 
formula-fed infants could be the amount of proteins, which 
is in general higher in formula feeding than in breastfeed-
ing [29]. Another higher appetite-regulating hormone in 
formula-fed infants was GIP, which plays an important 
role in the regulation of plasma glucose and insulin secre-
tion [30]. It is possible that higher GIP levels could account 
for an enhanced insulin release [31]. Also PP was higher in 
formula-fed infants. The function of PP is to self-regulate 
pancreatic secretion activities [32]. However, the mecha-
nism of how the type of feeding influences the GIP and PP 
levels is not fully understood. For further interpretation of 
the potential relevance of these findings, more research is 
required.
To our knowledge, this is the first large study investi-
gating the relationship between simultaneously measured 
serum levels of appetite-regulating hormones and detailed 
measurements of infant body composition, by air displace-
ment plethysmography (Peapod). We found a significant 
positive correlation between serum ghrelin and FM% at 
3 months in the formula-fed infants, but not in the breastfed 
group. Leptin was also correlated with FM% in both for-
mula-fed and breastfed groups. The associations of leptin 
with FM% could be explained by the known physiology of 
adipose tissue. During early life, the adipocytes proliferate 
and differentiate [33]. Leptin levels increase in parallel to 
the number of adipocytes during the last part of the third 
trimester during gestation and the first months of life [34]. 
We demonstrated that leptin levels in male infants were 
higher at 3 months than at 6 months. Serum insulin corre-
lated positively with gain in FM% between 1 and 3 months. 
Earlier studies showed a positive association of insulin and 
insulin resistance with fat mass in childhood and adulthood 
[35, 36]. The other appetite-regulating hormones such as 
PP and GIP did not associate with FM% or gain in FM% 
in the total group, which partly contrasted our expectations. 
There is a need for further studies to identify the underly-
ing mechanisms and potential implications for possible 
programming effects of serum appetite hormones on later 
body composition.
We could not identify differences in appetite-regulating 
hormones between boys and girls, which is in line with 
studies in older children and in a study with a subset of 
appetite-regulating hormones in infants [30, 37, 38].
We did not investigate hormone levels in breast milk. 
Some studies investigated levels of ghrelin, leptin or insu-
lin in breast milk [9, 39–42]. In these studies, associations 
between appetite-regulating hormones in breast milk and 
anthropometric data of infants were found. An unhealthy 
maternal diet can lead to an unfavorable appetite-regulating 
hormone profile in breast milk, but it is not clear by which 
mechanism this unfavorable profile in breast milk could 
influence infant growth as hormones will be degraded 
when passing the stomach. In our study, we only investi-
gated fasting levels of appetite-regulating hormones. We 
realize that several appetite-regulating hormones are low in 
fasting state [30], but our study shows that even in fasting 
state all hormones were different between the formula-fed 
and breastfed infants. It would be interesting to investigate 
appetite-regulating hormone levels before and after a meal, 
but in our study, it was found unethical to collect blood for 
research purpose twice in healthy infants.
In conclusion, we found significantly higher serum lev-
els of ghrelin, leptin, insulin, GIP and PP and lower serum 
levels of PYY in infants who received exclusive formula 
feeding for at least 3 months compared to breastfeeding. 
Besides associations of leptin, ghrelin and insulin with 
body composition in infants of 3 and 6 months of age, 
we could not identify other associations of serum appe-
tite-regulating hormones with body composition. Further 
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studies on appetite-regulating hormones and the interac-
tions between these and body composition later in infancy 
would be helpful to further elucidate whether appetite-reg-
ulating hormones contribute to the programming of meta-
bolic health in later life.
Acknowledgments We thank all the patients and their parents for 
participating in this study. We greatly acknowledge Mrs. J. van Nieu-
wkasteele, M. Huibregtse-Schouten and C. Bruinings-Vroombout, 
research nurses, for their assistance and help with the data collec-
tion. We also thank L. van der Zee for analyzing the appetite-regu-
lating hormones. Besides this, we thank Nutricia Research for their 
independent research grant. This study was an investigator-initiated 
study, and AHK received an independent research grant by Nutricia 
Research, The Netherlands.
Compliance with ethical standards 
Conflict of interest The authors have no disclosures or conflict of 
interest to declare.
Open Access This article is distributed under the terms of the Crea-
tive Commons Attribution 4.0 International License (http://crea-
tivecommons.org/licenses/by/4.0/), which permits unrestricted use, 
distribution, and reproduction in any medium, provided you give 
appropriate credit to the original author(s) and the source, provide a 
link to the Creative Commons license, and indicate if changes were 
made.
References
 1. Statistiek, C.B.v.d. Lengte en gewicht van personen, ondergewicht 
en overgewicht; vanaf 1981 (Website) 2012 25 October 2012 
[cited 2012 03 July 2012]. http://statline.cbs.nl/StatWeb/publicati
on/?DM=SLNL&PA=81565NED&D1=a&D2=0,l&D3=a&D4
=0&D5=0,10,20,30&HDR=T&STB=G1,G2,G3,G4&VW=T
 2. Singh AS et al (2008) Tracking of childhood overweight into adult-
hood: a systematic review of the literature. Obes Rev 9(5):474–488
 3. Tsiros MD et al (2011) Obesity: the new childhood disability? 
Obes Rev 12(1):26–36
 4. Reilly JJ (2006) Obesity in childhood and adolescence: evidence 
based clinical and public health perspectives. Postgrad Med J 
82(969):429–437
 5. Leunissen RW et al (2009) Timing and tempo of first-year rapid 
growth in relation to cardiovascular and metabolic risk profile in 
early adulthood. JAMA 301(21):2234–2242
 6. Ekelund U et al (2007) Association of weight gain in infancy 
and early childhood with metabolic risk in young adults. J Clin 
Endocrinol Metab 92(1):98–103
 7. Eriksson JG (2011) Early growth and coronary heart disease and 
type 2 diabetes: findings from the Helsinki Birth Cohort Study 
(HBCS). Am J Clin Nutr 94(6 Suppl):1799S–1802S
 8. Munzberg H, Morrison CD (2015) Structure, production and 
signaling of leptin. Metabolism 64(1):13–23
 9. Savino F et al (2008) Looking for a relation between serum lep-
tin concentration and body composition parameters in healthy 
term infants in the first 6 months of life. J Pediatr Gastroenterol 
Nutr 46(3):348–351
 10. Maric G et al (2014) The role of gut hormones in appetite regula-
tion (review). Acta Physiol Hung 101(4):395–407
 11. Heijboer AC et al (2006) Gut-brain axis: regulation of glucose 
metabolism. J Neuroendocrinol 18(12):883–894
 12. Baggio LL, Drucker DJ (2007) Biology of incretins: GLP-1 and 
GIP. Gastroenterology 132(6):2131–2157
 13. Iniguez G et al (2002) Fasting and post-glucose ghrelin levels in 
SGA infants: relationships with size and weight gain at one year 
of age. J Clin Endocrinol Metab 87(12):5830–5833
 14. Schonbeck Y et al (2011) Increase in prevalence of over-
weight in Dutch children and adolescents: a comparison of 
nationwide growth studies in 1980, 1997 and 2009. PLoS One 
6(11):e27608
 15. Ellis KJ et al (2007) Body-composition assessment in infancy: 
air-displacement plethysmography compared with a reference 
4-compartment model. Am J Clin Nutr 85(1):90–95
 16. Ma G et al (2004) Validation of a new pediatric air-displacement 
plethysmograph for assessing body composition in infants. Am J 
Clin Nutr 79(4):653–660
 17. Sainz RD, Urlando A (2003) Evaluation of a new pediatric air-
displacement plethysmograph for body-composition assessment 
by means of chemical analysis of bovine tissue phantoms. Am J 
Clin Nutr 77(2):364–370
 18. Urlando A, Dempster P, Aitkens S (2003) A new air displace-
ment plethysmograph for the measurement of body composition 
in infants. Pediatr Res 53(3):486–492
 19. De Lucia Rolfe E et al (2013) Ultrasound estimates of visceral 
and subcutaneous-abdominal adipose tissues in infancy. J Obes 
2013:951954
 20. Savino F et al (2005) Ghrelin, leptin and IGF-I levels in breast-
fed and formula-fed infants in the first years of life. Acta Paediatr 
94(5):531–537
 21. Steculorum SM et al (2015) Neonatal ghrelin programs 
development of hypothalamic feeding circuits. J Clin Invest 
125(2):846–858
 22. Collden G et al (2015) Neonatal overnutrition causes early alter-
ations in the central response to peripheral ghrelin. Mol Metab 
4(1):15–24
 23. Hayashida T et al (2002) Ghrelin in neonatal rats: distribution in 
stomach and its possible role. J Endocrinol 173(2):239–245
 24. Bouret SG, Draper SJ, Simerly RB (2004) Trophic action of 
leptin on hypothalamic neurons that regulate feeding. Science 
304(5667):108–110
 25. Petridou E et al (2005) Neonatal leptin levels are strongly associ-
ated with female gender, birth length, IGF-I levels and formula 
feeding. Clin Endocrinol (Oxf) 62(3):366–371
 26. Savino F et al (2004) Breast-fed infants have higher leptin values 
than formula-fed infants in the first four months of life. J Pediatr 
Endocrinol Metab 17(11):1527–1532
 27. Wojcicki JM (2012) Peptide YY in children: a review. J Pediatr 
Endocrinol Metab 25(3–4):227–232
 28. Perala MM et al (2013) Early growth and postprandial appetite 
regulatory hormone responses. Br J Nutr 110(9):1591–1600
 29. Ziegler EE (2006) Growth of breast-fed and formula-fed infants. 
Nestle Nutr Workshop Ser Pediatr Prog 58:51–59
 30. Huml M et al (2011) Gut peptide hormones and pediatric type 1 
diabetes mellitus. Physiol Res 60(4):647–658
 31. Le Huerou-Luron I, Blat S, Boudry G (2010) Breast-v. formula-
feeding: impacts on the digestive tract and immediate and long-
term health effects. Nutr Res Rev 23(1):23–36
 32. Batterham RL et al (2003) Pancreatic polypeptide reduces 
appetite and food intake in humans. J Clin Endocrinol Metab 
88(8):3989–3992
 33. Hernandez MI et al (2012) Leptin and IGF-I/II during the first 
weeks of life determine body composition at 2 years in infants 
born with very low birth weight. J Pediatr Endocrinol Metab 
25(9–10):951–955
 34. Granado M et al (2012) Leptin in early life: a key factor for 
the development of the adult metabolic profile. Obes Facts 
5(1):138–150
 Eur J Nutr
1 3
 35. Gishti O et al (2015) BMI, total and abdominal fat distribution, 
and cardiovascular risk factors in school-age children. Pediatr 
Res 77(5):710–718
 36. Paradisi G et al (1999) Dual energy X-ray absorptiometry assess-
ment of fat mass distribution and its association with the insulin 
resistance syndrome. Diabetes Care 22(8):1310–1317
 37. Fidanci K et al (2010) Ghrelin levels and postnatal growth in 
healthy infants 0–3 months of age. J Clin Res Pediatr Endocrinol 
2(1):34–38
 38. Wilasco MI et al (2012) Ghrelin, leptin and insulin in healthy 
children: Relationship with anthropometry, gender, and age dis-
tribution. Regul Pept 173(1–3):21–26
 39. Fields DA, Demerath EW (2012) Relationship of insulin, glu-
cose, leptin, IL-6 and TNF-alpha in human breast milk with 
infant growth and body composition. Pediatr Obes 7(4):304–312
 40. Kon IY et al (2014) The study of breast milk IGF-1, leptin, ghre-
lin and adiponectin levels as possible reasons of high weight gain 
in breast-fed infants. Ann Nutr Metab 65(4):317–323
 41. Savino F et al (2012) Resistin and leptin in breast milk and 
infants in early life. Early Hum Dev 88(10):779–782
 42. Savino F et al (2010) Evaluation of leptin in breast milk, lactat-
ing mothers and their infants. Eur J Clin Nutr 64(9):972–977
